Doxepin therapy postprandial symptomatic hypoglycaemic patients neurochemical hormonal metabolic disturbances oral glucose tolerance tests symptomatic postprandial hypoglycaemic patients placebo doxepin therapy doxepin therapy Plasma neurotransmitters parallel assays plasma insulin glucose levels different types patients Type low noradrenaline/adrenaline ratio high dopamine levels low platelet serotonin levels basal periods glucose load late peaks dopamine free symptoms nadir plasma glucose Type II low basal plasma noradrenaline/adrenaline ratio glucose load progressive increases adrenaline decreases glucose Adrenergic symptoms nadir glucose type III patients hyperinsulinaemia glucose load similar types patient hyperglycaemia sustained progressive reduction plasma glucose patients high basal noradrenaline/adrenaline ratio high basal plasma levels high basal levels platelet glucose load Systolic diastolic blood pressure paralleled reductions heart rate glucose nadir plasma glucose appearance symptoms weakness heartburn oppressive chest pain tension headache abdominal cramps dizziness Therapy doxepin disappearance symptoms weeks Normalization disordered variables cardiovascular metabolic neurochemical clonidine test disappearance symptoms Symptoms types patients hypoglycaemia-induced disorders plasma neurotransmitters se uncoping stress situation type II patients depression type III patients physiopathological mechanisms 